Yuetin T Wong, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 2 carriers
- Office
- 1
- Since medical school
- 18 years
- Albert Einstein College of Medicine of Yeshiva University, 2008
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
6 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wong’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A110707 · Current
Licensed to practise in California · since 2010 · expires 2028-01-31 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$662
Medicare paid this office $662 for 27 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Blood glucose (sugar) test performed by hand-held instrument | 25 | $109 | $3 |
Who their Medicare patients are
27 Original Medicare patients in 2024. Average age 66 · 85 and older 0% · Women 59% · Health risk score 1.95. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: Diabetes 75% · High blood pressure 74%.
The office billed $1,635, Medicare allowed $662 and paid $662; for 48 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 27 | 48 | 66 | 1.95 | $1,635 | $662 |
| 2019 | 16 | 403 | 70 | 1.11 | $13,517 | $1,896 |
| 2015 | 14 | 24 | 66 | 1.35 | $6,628 | $1,372 |
| 2014 | 25 | 117 | 73 | 0.69 | $4,350 | $1,175 |
| 2013 | 70 | 502 | 74 | 0.87 | $18,126 | $6,127 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2014: 4 services
| Blood test, lipids (cholesterol and triglycerides) | 18 | $241 | $13 |
| Blood test, comprehensive group of blood chemicals | 18 | $220 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $121 | $9 |
| Insertion of needle into vein for collection of blood sample | 23 | $74 | $3 |
2013: 10 services
| Vitamin d-3 level | 30 | $1,445 | $40 |
| Blood test, lipids (cholesterol and triglycerides) | 54 | $881 | $14 |
| Blood test, comprehensive group of blood chemicals | 61 | $876 | $12 |
| Blood test, thyroid stimulating hormone (tsh) | 19 | $455 | $23 |
| Hepatitis b surface antibody measurement | 28 | $407 | $15 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 28 | $392 | $14 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 37 | $367 | $9 |
| Hemoglobin a1c level | 16 | $329 | $13 |
| Insertion of needle into vein for collection of blood sample | 65 | $292 | $3 |
| Stool analysis for blood to screen for colon tumors | 31 | $137 | $4 |
Medicaid work
$1,131,287 in 2024
Medicaid paid $1,131,287 for 23,371 billed services this clinician did in 2024, up to 314 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,526 | $966,585 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 241 | $139,364 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 219 | $11,572 |
| Short return visit (20+ min) | 3,568 | $7,262 |
| Return visit (30+ min) | 772 | $2,143 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 39 | $1,524 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 183 | $775 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 704 | $679 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 93 | $523 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 16 | $400 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 83 | $317 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 337 | $116 |
| 2024 | 23,371 | 32 | 314 | $1,131,287 |
| 2023 | 10,585 | 21 | 230 | $980,306 |
| 2022 | 6,928 | 23 | 162 | $811,917 |
| 2021 | 4,415 | 24 | 134 | $671,232 |
| 2020 | 5,195 | 20 | 145 | $379,500 |
| 2019 | 2,397 | 19 | 103 | $192,708 |
| 2018 | 4,413 | 20 | 152 | $607,991 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,534 | $933,992 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 37 | $20,838 |
| Short return visit (20+ min) | 3,097 | $8,967 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 304 | $6,410 |
| Return visit (30+ min) | 806 | $4,912 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 95 | $2,665 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 349 | $1,443 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 881 | $557 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 52 | $343 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 258 | $92 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 81 | $87 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 367 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,349 | $797,783 |
| Short return visit (20+ min) | 2,199 | $7,615 |
| Return visit (30+ min) | 559 | $2,819 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 71 | $1,155 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 280 | $661 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 12 | $480 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 66 | $447 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 355 | $265 |
| Short return visit | 136 | $241 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $182 |
| Hemoglobin A1C level | 14 | $154 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 19 | $53 |
2021
| Clinic visit/encounter, all-inclusive | 1,270 | $660,144 |
| Short return visit (20+ min) | 1,496 | $2,335 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 53 | $2,100 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 41 | $1,640 |
| Hemoglobin A1C level | 148 | $1,628 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 21 | $840 |
| Blood test, lipids (cholesterol and triglycerides) | 54 | $820 |
| Short return visit | 161 | $447 |
| Return visit (30+ min) | 141 | $284 |
| Thyroid stimulating hormone (TSH) | 14 | $267 |
| ELECTROLYTE PANEL | 29 | $231 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 84 | $208 |
2020
| Clinic visit/encounter, all-inclusive | 1,546 | $366,245 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 407 | $3,241 |
| Hemoglobin A1C level | 189 | $2,079 |
| Blood test, lipids (cholesterol and triglycerides) | 111 | $1,685 |
| Short return visit (20+ min) | 1,164 | $1,429 |
| Thyroid stimulating hormone (TSH) | 60 | $1,142 |
| ELECTROLYTE PANEL | 123 | $978 |
| Return visit (30+ min) | 319 | $649 |
| Creatinine; blood | 265 | $528 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 54 | $476 |
| Short return visit | 375 | $326 |
| HEPATIC FUNCTION PANEL | 42 | $180 |
2019
| Clinic visit/encounter, all-inclusive | 719 | $188,237 |
| Short return visit (20+ min) | 700 | $1,264 |
| Return visit (30+ min) | 371 | $689 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 80 | $497 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 24 | $389 |
| Blood test, lipids (cholesterol and triglycerides) | 23 | $349 |
| Thyroid stimulating hormone (TSH) | 17 | $324 |
| Hemoglobin A1C level | 21 | $231 |
| Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations | 13 | $147 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 16 | $141 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 13 | $125 |
| ELECTROLYTE PANEL | 15 | $119 |
2018
| Clinic visit/encounter, all-inclusive | 2,158 | $597,586 |
| Short return visit (20+ min) | 885 | $3,856 |
| Return visit (30+ min) | 513 | $2,355 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 117 | $977 |
| Hemoglobin A1C level | 58 | $638 |
| Blood test, lipids (cholesterol and triglycerides) | 38 | $577 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 79 | $400 |
| Thyroid stimulating hormone (TSH) | 18 | $343 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 38 | $335 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 126 | $240 |
| ELECTROLYTE PANEL | 23 | $183 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 15 | $144 |
Drugs they prescribed that Part D paid
$126,114
Pharmacies billed $126,114 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (36 of 2,142) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,928 generic and 202 brand-name prescriptions · $126,114 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 21 | $29,577 | $1,408 |
| Eliquis | 11 | $13,252 | $1,205 |
| Doxepin | 15 | $4,934 | $329 |
| Buprenorphine-Naloxone | 16 | $2,109 | $132 |
| Novolin 70-30 | 12 | $1,704 | $142 |
See all 47 drugs
| Jardiance | 21 | $29,577 | $1,408 |
| Eliquis | 11 | $13,252 | $1,205 |
| Doxepin | 15 | $4,934 | $329 |
| Buprenorphine-Naloxone | 16 | $2,109 | $132 |
| Novolin 70-30 | 12 | $1,704 | $142 |
| Atorvastatin | 187 | $1,178 | $6 |
| Glycopyrrolate | 12 | $1,126 | $94 |
| Levothyroxine | 92 | $1,066 | $12 |
| Losartan | 147 | $947 | $6 |
| Albuterol Sulfate Hfa | 15 | $820 | $55 |
| Gabapentin | 44 | $688 | $16 |
| Primidone | 15 | $680 | $45 |
| Amlodipine Besylate | 191 | $578 | $3 |
| Fosinopril | 26 | $485 | $19 |
| Pravastatin | 45 | $461 | $10 |
| Lisinopril | 33 | $419 | $13 |
| Tamsulosin | 46 | $413 | $9 |
| Metformin | 83 | $385 | $5 |
| Fluticasone Propionate | 40 | $341 | $9 |
| Metoprolol | 31 | $313 | $10 |
| Mirtazapine | 14 | $297 | $21 |
| Omeprazole | 45 | $290 | $6 |
| Alendronate | 46 | $281 | $6 |
| Baclofen | 60 | $273 | $5 |
| Finasteride | 29 | $271 | $9 |
| Rizatriptan | 16 | $265 | $17 |
| Carbidopa-Levodopa | 14 | $263 | $19 |
| Ketoconazole | 17 | $234 | $14 |
| Clopidogrel | 29 | $225 | $8 |
| Isosorbide Mononitrate Er | 22 | $217 | $10 |
| Triamcinolone Acetonide | 35 | $186 | $5 |
| Trazodone | 22 | $179 | $8 |
| Montelukast | 15 | $146 | $10 |
| Metoprolol | 32 | $141 | $4 |
| Carvedilol | 19 | $133 | $7 |
| Simvastatin | 33 | $130 | $4 |
| Tramadol | 13 | $128 | $10 |
| Nitroglycerin | 18 | $127 | $7 |
| Benazepril | 11 | $126 | $11 |
| Hydrocortisone | 15 | $117 | $8 |
| Famotidine | 24 | $112 | $5 |
| Hydroxyzine | 13 | $83 | $6 |
| Ibuprofen | 12 | $83 | $7 |
| Rosuvastatin | 11 | $80 | $7 |
| Sertraline | 13 | $71 | $5 |
| Zolpidem | 16 | $51 | $3 |
| Hydrochlorothiazide | 12 | $25 | $2 |
Year by year
| 2024 | 2,142 | 182 | 2% (36) | 9% | $126,114 |
| 2023 | 2,062 | 182 | 2% (48) | None | $154,645 |
| 2022 | 1,996 | 219 | 3% (54) | None | $151,983 |
| 2021 | 1,565 | 150 | 1% (20) | None | $124,914 |
| 2020 | 1,162 | 95 | 1% (13) | None | $80,064 |
| 2019 | 570 | 83 | None | 11% | $28,628 |
| 2018 | 584 | 77 | 3% (18) | None | $17,009 |
| 2017 | 318 | 50 | None | None | $7,131 |
| 2016 | 1,099 | 170 | 3% (28) | 15% | $61,116 |
| 2015 | 1,514 | 167 | 5% (68) | 16% | $96,153 |
| 2014 | 831 | 140 | 3% (25) | 17% | $35,020 |
| 2013 | 909 | 101 | None | 20% | $36,991 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Vascepa | 25 | $9,440 | $378 |
| Exelon | 12 | $8,894 | $741 |
| Novolin 70-30 | 14 | $6,248 | $446 |
| Advair Diskus | 16 | $6,130 | $383 |
| Flovent Hfa | 19 | $4,921 | $259 |
| Atorvastatin | 165 | $4,176 | $25 |
| Losartan | 102 | $3,109 | $30 |
| Amlodipine Besylate | 165 | $2,937 | $18 |
| Levothyroxine | 87 | $2,223 | $26 |
| Omeprazole | 69 | $1,928 | $28 |
| Buprenorphine-Naloxone | 15 | $1,847 | $123 |
| Primidone | 12 | $1,738 | $145 |
| Tamsulosin | 40 | $1,466 | $37 |
| Albuterol Sulfate Hfa | 28 | $1,271 | $45 |
| Metformin | 84 | $1,250 | $15 |
| Alendronate | 54 | $1,216 | $23 |
| Gabapentin | 51 | $1,102 | $22 |
| Baclofen | 57 | $1,032 | $18 |
| Glycopyrrolate | 12 | $947 | $79 |
| Finasteride | 23 | $887 | $39 |
| Calcium Acetate | 13 | $860 | $66 |
| Pravastatin | 36 | $739 | $21 |
| Fosinopril | 29 | $715 | $25 |
| Metoprolol | 36 | $638 | $18 |
| Lisinopril | 27 | $621 | $23 |
| Diclofenac | 18 | $561 | $31 |
| Isosorbide Mononitrate Er | 14 | $514 | $37 |
| Metoprolol | 33 | $485 | $15 |
| Famotidine | 39 | $477 | $12 |
| Simvastatin | 33 | $472 | $14 |
| Clopidogrel | 29 | $433 | $15 |
| Trazodone | 25 | $431 | $17 |
| Rizatriptan | 15 | $398 | $27 |
| Carbidopa-Levodopa | 13 | $364 | $28 |
| Fluticasone Propionate | 28 | $348 | $12 |
| Triamcinolone Acetonide | 37 | $329 | $9 |
| Furosemide | 17 | $303 | $18 |
| Hydrocortisone | 24 | $264 | $11 |
| Sertraline | 11 | $262 | $24 |
| Carvedilol | 19 | $234 | $12 |
| Ketoconazole | 16 | $226 | $14 |
| Acetaminophen-Codeine | 22 | $189 | $9 |
| Ibuprofen | 15 | $134 | $9 |
| Zolpidem | 12 | $98 | $8 |
| Acyclovir | 12 | $86 | $7 |
| Hydrochlorothiazide | 15 | $44 | $3 |
2022: 49 drugs
| Xarelto | 14 | $15,672 | $1,119 |
| Spiriva Handihaler | 15 | $9,639 | $643 |
| Exelon | 11 | $8,155 | $741 |
| Eliquis | 13 | $6,924 | $533 |
| Vascepa | 18 | $6,901 | $383 |
| Atorvastatin | 152 | $3,085 | $20 |
| Baclofen | 65 | $2,513 | $39 |
| Duloxetine | 12 | $2,461 | $205 |
| Levothyroxine | 89 | $2,197 | $25 |
| Buprenorphine-Naloxone | 17 | $1,877 | $110 |
| Gabapentin | 43 | $1,449 | $34 |
| Losartan | 95 | $1,417 | $15 |
| Amlodipine Besylate | 113 | $1,159 | $10 |
| Omeprazole | 59 | $1,137 | $19 |
| Alendronate | 56 | $810 | $14 |
| Calcium Acetate | 13 | $792 | $61 |
| Metformin | 101 | $769 | $8 |
| Metoprolol | 42 | $761 | $18 |
| Rizatriptan | 15 | $723 | $48 |
| Glycopyrrolate | 11 | $684 | $62 |
| Ventolin Hfa | 11 | $677 | $62 |
| Fosinopril | 27 | $661 | $24 |
| Primidone | 12 | $596 | $50 |
| Clopidogrel | 30 | $483 | $16 |
| Diclofenac | 17 | $474 | $28 |
| Pravastatin | 22 | $471 | $21 |
| Tamsulosin | 38 | $469 | $12 |
| Finasteride | 22 | $444 | $20 |
| Trazodone | 27 | $438 | $16 |
| Lactulose | 13 | $408 | $31 |
| Simvastatin | 42 | $385 | $9 |
| Triamcinolone Acetonide | 33 | $360 | $11 |
| Metoprolol | 33 | $337 | $10 |
| Lisinopril | 22 | $327 | $15 |
| Carbidopa-Levodopa | 22 | $318 | $14 |
| Pantoprazole | 13 | $280 | $22 |
| Dicyclomine | 15 | $280 | $19 |
| Fluticasone Propionate | 28 | $266 | $9 |
| Glipizide | 26 | $250 | $10 |
| Citalopram Hbr | 13 | $240 | $18 |
| Furosemide | 33 | $209 | $6 |
| Sumatriptan | 11 | $177 | $16 |
| Famotidine | 20 | $173 | $9 |
| Sertraline | 18 | $165 | $9 |
| Acetaminophen-Codeine | 14 | $119 | $9 |
| Ibuprofen | 18 | $115 | $6 |
| Oxybutynin Chloride | 11 | $108 | $10 |
| Tramadol | 15 | $89 | $6 |
| Hydrochlorothiazide | 17 | $55 | $3 |
2021: 36 drugs
| Spiriva | 17 | $10,523 | $619 |
| Buprenorphine-Naloxone | 26 | $2,803 | $108 |
| Levothyroxine | 61 | $1,510 | $25 |
| Atorvastatin | 118 | $1,474 | $12 |
| Carbidopa-Levodopa | 18 | $1,074 | $60 |
| Baclofen | 64 | $1,015 | $16 |
| Lidocaine | 11 | $989 | $90 |
| Calcium Acetate | 12 | $909 | $76 |
| Gabapentin | 42 | $753 | $18 |
| Losartan | 61 | $668 | $11 |
| Amlodipine Besylate | 78 | $584 | $7 |
| Metformin | 84 | $521 | $6 |
| Omeprazole | 61 | $492 | $8 |
| Fosinopril | 23 | $429 | $19 |
| Alendronate | 70 | $421 | $6 |
| Finasteride | 17 | $334 | $20 |
| Tamsulosin | 21 | $305 | $15 |
| Oxybutynin Chloride | 25 | $300 | $12 |
| Lactulose | 22 | $280 | $13 |
| Triamcinolone Acetonide | 21 | $261 | $12 |
| Doxazosin Mesylate | 12 | $254 | $21 |
| Glipizide | 28 | $253 | $9 |
| Pravastatin | 13 | $250 | $19 |
| Simvastatin | 38 | $229 | $6 |
| Lisinopril | 18 | $216 | $12 |
| Metoprolol | 21 | $213 | $10 |
| Clopidogrel | 28 | $211 | $8 |
| Acetaminophen-Codeine | 14 | $206 | $15 |
| Glycopyrrolate | 13 | $204 | $16 |
| Furosemide | 28 | $203 | $7 |
| Fluticasone Propionate | 22 | $193 | $9 |
| Trazodone | 16 | $173 | $11 |
| Famotidine | 13 | $146 | $11 |
| Rizatriptan | 11 | $129 | $12 |
| Sertraline | 20 | $102 | $5 |
| Hydrochlorothiazide | 15 | $84 | $6 |
2020: 35 drugs
| Zubsolv | 11 | $12,830 | $1,166 |
| Spiriva | 15 | $10,116 | $674 |
| Exelon | 12 | $9,934 | $828 |
| Symbicort | 11 | $3,521 | $320 |
| Levothyroxine | 60 | $1,416 | $24 |
| Gabapentin | 51 | $1,085 | $21 |
| Buprenorphine-Naloxone | 12 | $974 | $81 |
| Atorvastatin | 66 | $854 | $13 |
| Baclofen | 54 | $601 | $11 |
| Losartan | 39 | $435 | $11 |
| Fosinopril | 21 | $383 | $18 |
| Carbidopa-Levodopa | 18 | $360 | $20 |
| Omeprazole | 45 | $353 | $8 |
| Amlodipine Besylate | 57 | $317 | $6 |
| Diclofenac | 13 | $317 | $24 |
| Metformin | 43 | $302 | $7 |
| Doxazosin Mesylate | 14 | $294 | $21 |
| Alendronate | 49 | $230 | $5 |
| Oxybutynin Chloride | 16 | $206 | $13 |
| Fluticasone Propionate | 19 | $152 | $8 |
| Furosemide | 30 | $149 | $5 |
| Simvastatin | 25 | $127 | $5 |
| Trazodone | 18 | $127 | $7 |
| Escitalopram | 11 | $120 | $11 |
| Benazepril | 11 | $116 | $11 |
| Finasteride | 11 | $101 | $9 |
| Clonazepam | 11 | $92 | $8 |
| Pantoprazole | 13 | $90 | $7 |
| Tamsulosin | 13 | $90 | $7 |
| Lisinopril | 15 | $88 | $6 |
| Glipizide | 13 | $88 | $7 |
| Ibuprofen | 16 | $76 | $5 |
| Triamcinolone Acetonide | 12 | $73 | $6 |
| Hydrochlorothiazide | 15 | $51 | $3 |
| Metoprolol | 12 | $26 | $2 |
2019: 17 drugs
| Levothyroxine | 18 | $537 | $30 |
| Atorvastatin | 35 | $488 | $14 |
| Gabapentin | 23 | $381 | $17 |
| Trazodone | 23 | $275 | $12 |
| Alendronate | 27 | $215 | $8 |
| Tamsulosin | 11 | $191 | $17 |
| Losartan | 20 | $188 | $9 |
| Baclofen | 13 | $182 | $14 |
| Amlodipine Besylate | 18 | $151 | $8 |
| Carbidopa-Levodopa | 11 | $144 | $13 |
| Metformin | 17 | $139 | $8 |
| Lisinopril | 11 | $116 | $11 |
| Simvastatin | 15 | $115 | $8 |
| Omeprazole | 15 | $102 | $7 |
| Furosemide | 15 | $95 | $6 |
| Ibuprofen | 12 | $90 | $8 |
| Metoprolol | 11 | $61 | $6 |
2018: 15 drugs
| Levothyroxine | 21 | $636 | $30 |
| Atorvastatin | 32 | $430 | $13 |
| Fosinopril | 14 | $255 | $18 |
| Metformin | 29 | $235 | $8 |
| Alendronate | 30 | $209 | $7 |
| Losartan | 29 | $208 | $7 |
| Amlodipine Besylate | 28 | $180 | $6 |
| Trazodone | 20 | $169 | $8 |
| Carbidopa-Levodopa | 13 | $161 | $12 |
| Benazepril | 13 | $141 | $11 |
| Omeprazole | 14 | $132 | $9 |
| Ibuprofen | 17 | $87 | $5 |
| Metoprolol | 11 | $80 | $7 |
| Furosemide | 11 | $77 | $7 |
| Baclofen | 11 | $56 | $5 |
2017: 8 drugs
| Levothyroxine | 16 | $442 | $28 |
| Atorvastatin | 24 | $406 | $17 |
| Gabapentin | 13 | $217 | $17 |
| Losartan | 18 | $160 | $9 |
| Metformin | 13 | $127 | $10 |
| Alendronate | 13 | $96 | $7 |
| Baclofen | 12 | $84 | $7 |
| Omeprazole | 12 | $74 | $6 |
2016: 30 drugs
| Levothyroxine | 43 | $1,467 | $34 |
| Gabapentin | 50 | $1,147 | $23 |
| Proair Hfa | 15 | $831 | $55 |
| Ventolin Hfa | 14 | $765 | $55 |
| Atorvastatin | 50 | $742 | $15 |
| Bd Ultra-Fine Pen Needle | 11 | $626 | $57 |
| Fosinopril | 29 | $520 | $18 |
| Metoprolol | 12 | $467 | $39 |
| Metformin | 39 | $383 | $10 |
| Pioglitazone | 22 | $375 | $17 |
| Omeprazole | 36 | $347 | $10 |
| Metoprolol | 16 | $313 | $20 |
| Simvastatin | 36 | $311 | $9 |
| Hydrocodone-Acetaminophen | 18 | $295 | $16 |
| Amlodipine Besylate | 49 | $253 | $5 |
| Hydrochlorothiazide | 33 | $244 | $7 |
| Lisinopril | 31 | $214 | $7 |
| Losartan | 27 | $206 | $8 |
| Baclofen | 14 | $174 | $12 |
| Glipizide | 20 | $167 | $8 |
| Fluticasone Propionate | 18 | $142 | $8 |
| Ibuprofen | 25 | $133 | $5 |
| Sertraline | 12 | $118 | $10 |
| Atenolol | 25 | $107 | $4 |
| Alendronate | 20 | $100 | $5 |
| Trazodone | 21 | $98 | $5 |
| Naproxen | 16 | $96 | $6 |
| Fluoxetine | 11 | $91 | $8 |
| Ranitidine | 11 | $76 | $7 |
| Furosemide | 13 | $72 | $6 |
2015: 38 drugs
| Lantus Solostar | 19 | $8,645 | $455 |
| Gabapentin | 74 | $1,331 | $18 |
| Levothyroxine | 38 | $1,229 | $32 |
| Metformin Hcl Er | 11 | $1,124 | $102 |
| Proair Hfa | 23 | $1,108 | $48 |
| Atorvastatin | 59 | $954 | $16 |
| Metoprolol | 18 | $867 | $48 |
| Bd Ultra-Fine Pen Needle | 14 | $821 | $59 |
| Chlorthalidone | 22 | $774 | $35 |
| Fosinopril | 49 | $757 | $15 |
| Hydrocodone-Acetaminophen | 40 | $675 | $17 |
| Amlodipine Besylate | 60 | $491 | $8 |
| Metformin | 51 | $445 | $9 |
| Ibuprofen | 73 | $444 | $6 |
| Pioglitazone | 27 | $386 | $14 |
| Omeprazole | 35 | $360 | $10 |
| Doxazosin Mesylate | 15 | $324 | $22 |
| Trazodone | 50 | $301 | $6 |
| Simvastatin | 40 | $275 | $7 |
| Losartan | 34 | $263 | $8 |
| Metoprolol | 18 | $225 | $13 |
| Baclofen | 15 | $223 | $15 |
| Zolpidem | 13 | $222 | $17 |
| Fluticasone Propionate | 23 | $192 | $8 |
| Hydrochlorothiazide | 31 | $190 | $6 |
| Furosemide | 19 | $183 | $10 |
| Alendronate | 26 | $177 | $7 |
| Glipizide | 26 | $152 | $6 |
| Lisinopril | 23 | $151 | $7 |
| Atenolol | 27 | $147 | $5 |
| Sertraline | 14 | $124 | $9 |
| Lorazepam | 17 | $115 | $7 |
| Naproxen | 16 | $114 | $7 |
| Triamcinolone Acetonide | 12 | $106 | $9 |
| Citalopram Hbr | 11 | $104 | $9 |
| Carvedilol | 12 | $95 | $8 |
| Ranitidine | 15 | $83 | $6 |
| Prednisone | 16 | $67 | $4 |
2014: 22 drugs
| Lantus | 18 | $3,878 | $215 |
| Simvastatin | 67 | $580 | $9 |
| Atorvastatin | 18 | $546 | $30 |
| Amlodipine Besylate | 78 | $541 | $7 |
| Tamsulosin | 26 | $451 | $17 |
| Gabapentin | 18 | $382 | $21 |
| Levothyroxine | 18 | $338 | $19 |
| Glipizide | 25 | $318 | $13 |
| Losartan | 28 | $305 | $11 |
| Metformin | 24 | $299 | $12 |
| Fosinopril | 14 | $298 | $21 |
| Hydrocodone-Acetaminophen | 17 | $257 | $15 |
| Alendronate | 15 | $218 | $15 |
| Lisinopril | 36 | $204 | $6 |
| Ibuprofen | 28 | $148 | $5 |
| Escitalopram | 15 | $137 | $9 |
| Paroxetine | 12 | $134 | $11 |
| Omeprazole | 12 | $111 | $9 |
| Clonazepam | 15 | $93 | $6 |
| Terazosin | 12 | $76 | $6 |
| Trazodone | 15 | $59 | $4 |
| Hydrochlorothiazide | 12 | $54 | $4 |
2013: 27 drugs
| Diovan | 18 | $5,323 | $296 |
| Lantus | 27 | $4,287 | $159 |
| Novolog Flexpen | 12 | $3,617 | $301 |
| Clopidogrel | 14 | $1,429 | $102 |
| Simvastatin | 100 | $1,034 | $10 |
| Boostrix Tdap | 15 | $850 | $57 |
| Metoprolol | 15 | $666 | $44 |
| Amlodipine Besylate | 71 | $647 | $9 |
| Losartan | 40 | $592 | $15 |
| Lisinopril | 77 | $572 | $7 |
| Alendronate | 36 | $498 | $14 |
| Bd Ultra-Fine Pen Needle | 12 | $416 | $35 |
| Tamsulosin | 27 | $411 | $15 |
| Metformin | 31 | $383 | $12 |
| Pravastatin | 14 | $281 | $20 |
| Atorvastatin | 12 | $208 | $17 |
| Losartan-Hydrochlorothiazide | 20 | $184 | $9 |
| Omeprazole | 18 | $173 | $10 |
| Glipizide | 25 | $166 | $7 |
| Terazosin | 14 | $147 | $11 |
| Paroxetine | 14 | $133 | $9 |
| Ranitidine | 17 | $126 | $7 |
| Citalopram Hbr | 12 | $91 | $8 |
| Ibuprofen | 18 | $71 | $4 |
| Metoprolol | 16 | $69 | $4 |
| Clonazepam | 13 | $68 | $5 |
| Hydrochlorothiazide | 14 | $46 | $3 |
Professional record
- NPI
- 1922399021
- Licence
- CA A110707California A110707: Current · expires 2028-01-31
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2008 · 18 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1520 Stockton St, San Francisco, CA, 94133
- NPI first listed
- 2011-04-22
- NPI last updated
- 2013-04-23
This is when the NPI record was last certified, not a medical board exam.